Johnson , M.com

, headquartered in Minneapolis, is the world's
leading medical technology company , providing lifelong solutions for
people with chronic disease. Actual results may differ
materially from anticipated results.
In the PMA, the Company is seeking FDA approval to sell kit
versions of its AlzheimAlert(TM) test to qualified laboratories and
hospitals in the United States.

transhumanism sentient

D.,
and Krishnendu Roy, Ph.J. The test measures levels of a brain protein
called neural thread protein (NTP ) known to be elevated in the brain
tissue, cerebrospinal fluid and urine of patients with Alzheimer 's
disease.com, email:
info@nymox.

electrically circuits

and Co-Editor-in-Chief of Tissue Engineering., is a privately held, fully integrated
media company known for establishing authoritative peer-reviewed
journals in many promising areas of science and biomedical research,
including Human Gene Therapy, Stem Cells and Development, and Cloning
and Stem Cells.

Medtronic Brain Pacing Technology Successfully Used in Preliminary Depression Clinical Study

AlzheimAlert(TM) is already certified as a laboratory testing
service in the U. Such factors are detailed from time to time in Nymox's
filings with the United States Securities and Exchange Commission and
other regulatory authorities.

brain electrically

Superior Growth and Differentiation of Embryonic Stem Cells on 3-Dimensional Bio-Scaffold Reported in Tissue Engineering

Business Editors/Biotech Writers
BIOWIRE2K

LARCHMONT, N. The authors reported a reproducible 2-fold increase in the
efficiency of hematopoietic precursor cell generation on the 3-D
matrix. A complete list of the firm's
60 journals, books, and newsmagazines is available at
www.com

Any forward -looking statements are subject to risks and
uncertainties as described in Medtronic's Annual Report on Form 10-K
for the year ended April 30, 2004.

rid preliminary

This is commonly called deep brain
stimulation .----Nymox
Pharmaceutical Corporation (NASDAQ:NYMX) announced today that it has
been informed that the Company's Premarket Approval (PMA) application
to FDA concerning a kit version of the Company 's AlzheimAlert(TM)
urine test will be going forward to a presentation before a panel of
the Medical Devices Advisory Committee.

thoughts wireheading

The study,
published in the March 3 edition of the journal Neuron saw a strong
and sustained reduction in depression in four of the six patients
evaluated.
There is an extensive scientific and medical literature on the
usefulness of NTP as a biomarker for Alzheimer 's disease. The conduct of clinical trials and
the development of drug products involve substantial risks and
uncertainties and actual results may differ materially from
expectations.

beings neural

, from the University of Texas at Austin,
showed that mouse ES cells achieved more efficient hematopoietic
differentiation than they do when grown in traditional 2-D suspension
cultures.liebertpub.

beings stimulating

brain suffering

The results of this study support ongoing scientific research on
deep brain stimulation (DBS) and provide hope for thousands of
patients suffering from treatment-resistant depression and other
neurological disorders. The Kinetra accommodates two extensions/leads, and thus
provides bilateral neurostimulation from a single neurostimulator.

interfacing neurological

Pharmaceutical Writers/Business Editors

MAYWOOD, N.

usefulness neural

As the leader in DBS therapy with its
Activa(R) therapy, Medtronic is actively supporting research in the
psychiatric field.

preliminary pleasure

Tissue Engineering is an authoritative peer-reviewed journal
published monthly in print and online that brings together scientific
and medical experts in the fields of biomedical engineering , material
science, molecular and cellular biology, and genetic engineering. Tables of contents and a free sample
issue may be viewed online at www.
This same technology is also currently being evaluated in a
Medtronic-sponsored multi-center US clinical trial as a therapy for
treatment resistant epilepsy. The date for the panel meeting will be
confirmed in due course.

sentient genetic

beings neural

Tissue Engineering is the official journal of the Tissue Engineering
Society international, European Tissue Engineering Society and the
Asian Tissue Engineering Society. AlzheimAlert(TM) is the Company's
proprietary urine test intended to aid physicians in the diagnosis of
Alzheimer's disease.

beings interfacing

The paper is available free online at
www. Its biotechnology trade magazine, Genetic Engineering
News (GEN), was the first in its field and is today the industry's
most widely read publication worldwide.liebertpub .

Business Editors/Health Editors

MINNEAPOLIS----Medtronic, Inc.

Nymox PMA Slated for FDA Advisory Panel Meeting

neurological sentient

D. Medtronic also is
actively evaluating DBS in the treatment of patients suffering from
depression and holds issued intellectual property in this area. This step follows the
submission of further data and analyses by the Company in October and
December 2004 and March 2005.

orgasmic emotional

Not only did the ES cells grown on the bio-scaffold develop
embryoid bodies, but instead of aggregating as they tend to do in 2-D
cultures, the embryoid bodies also integrated into the scaffolds and
appeared to be covered by an extracellular matrix. Specifically, Medtronic is working with the FDA to
introduce a DBS therapy for obsessive compulsive disorder utilizing
its patented technology under a humanitarian device exemption (HDE)
which it hopes to receive in the coming fiscal year.

To date, more than 25,000 patients
worldwide have benefited from Activa therapy.medtronic. A kit version of
AlzheimAlert(TM) is also available for sale in Europe as a result of
its certification with a CE Mark, making the test kit eligible for
sale in the European Union.

beings interfacing

, Chief Business Officer and Chief Medical
Officer at Icoria, Inc. FDA considers such recommendations but is not bound
by them when making its final decision about whether to approve the
Company's PMA.

suffering wireheading

Y.
"This work continues to push forward the identification of optimal
environments for the guidance of differentiation responses in
engineered tissues, a highly important focus for this field," says
Peter C. It uses one or two surgically
implanted medical devices called neurostimulators, similar to cardiac
pacemakers , to deliver electrical stimulation to precisely targeted
areas on each side of the brain.com

This press release contains certain "forward-looking statements"
as defined in the United States Private Securities Litigation Reform
Act of 1995 that involve a number of risks and uncertainties . Promising early results do not ensure that later stage
or larger scale clinical trials will be successful or will proceed as
expected.

pleasure molecular

liebertpub.

preliminary controversial

Using an innovative
3-D microenvironment composed of highly porous tantalum-based
scaffolds maintained in a spinner flask bioreactor, Hui Liu, Ph.D.com/ten

Mary Ann Liebert, Inc.

molecular emotional

(NYSE:MDT) announced today that its Kinetra(R) Dual-Channel
Neurostimulator and leads were used in a successful feasibility study
of patients suffering from treatment-resistant depression. Publications
include, for example, Journal of Alzheimer's Disease (2004; 6(3):
231 -42) and (2001; 3: 345-353); Cellular and Molecular Life Sciences
(2003; 60: 2679-91) and (2001; 58: 844-849); Alzheimer's Reports
(2002; 1: 1-6); Neurology + Clinical Neurophysiology (2002; 1: 2-7 );
Frontiers in Bioscience (2002; 7:d989-96); Journal of Neuropathology
and Experimental Neurology (2001; 60: 195-207) and (1996; 55:
1038-1050); Neurology (2000; 55: 1068) and (2000; 54: 1498-1504 );
Alzheimer's Reports (2001; 4: 61-65), (2000; 3: 177-184) and (1999; 2:
327-332); Journal of Clinical Laboratory Analysis (1998; 12: 285-288)
and (1998; 12: 223-226); Journal of Contemporary Neurology (1998; 4A:
2-6); and Journal of Clinical Investigation (1997; 100: 3093-3104).

wireheading beings

----Embryonic stem
cells grown on three-dimensional biocompatible scaffolds exhibited
more efficient differentiation into a variety of hematopoietic
progenitor cells, as reported in the February (Volume 11, Number 1-2)
issue of Tissue Engineering, a peer-reviewed journal published by Mary
Ann Liebert, Inc.

About Activa Therapy

Activa Therapy is currently an approved treatment option for
people with debilitating movement disorders, such as advanced
Parkinson's disease and Dystonia .
Medtronic, Inc.
Advisory panels provide FDA with recognized expertise, independent
judgment and recommendations about the safety and effectiveness of
medical devices.
More information about Nymox is available at www. There
can be no assurance that such statements will prove to be accurate and
the actual results and future events could differ materially from
management's current expectations .

sentient brain

nymox.

thoughts preliminary

com/ten
Generating hematopoietic cell lineages directly from embryonic
stem (ES) cells remains a significant challenge. Its website is www.S. through the Company's CLIA-certified clinical
reference laboratory in Maywood, New Jersey.

rid electrically

---

- - kjjkjk

Loading...

(Note: These pages use the Atlas Content Safeguard System (ACSS) and require that Javascript is enabled for viewing.)